Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Share Gainers
Why Core Lithium, Regis Resources, Spartan, and Volpara shares are jumping today
Healthcare Shares
ASX healthcare stock Volpara rockets 43% after accepting takeover offer
Opinions
School-leaver to retiree: ASX stocks I'd buy for each age bracket
Opinions
I'd invest $10,000 into these excellent ASX shares for the long-term
Cheap Shares
I'd start snapping up quality cheap ASX shares before stock prices start rising!
Healthcare Shares
Why is the Volpara share price rocketing 13% today?
Opinions
ASX wealth: How I'd aim to turn $50,000 into $500,000 for retirement
Growth Shares
2 ASX growth shares I'd buy over Nvidia
Growth Shares
2 ASX growth shares I rate as buys for their big potential
Growth Shares
3 ASX growth shares I'd buy with $1,500 right now
Small Cap Shares
Why I'd buy small-cap shares over ASX blue chips at every chance
How to invest
How I'd build a 'best ASX stocks to buy right now' list
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.